Protein aggregation in wound fluid confines bacterial lipopolysaccharide and reduces inflammation
Bacterial lipopolysaccharide (LPS) induces the rapid formation of protein aggregates in human wound fluid. We aimed to define such LPS-induced aggregates and the functional consequences of protein aggregation using a combination of mass spectrometry analyses, biochemical imaging, and experimental animal models. We show that such wound-fluid aggregates contain a multitude of protein classes, including sequences from coagulation factors, annexins, histones, antimicrobial proteins/peptides, and apolipoproteins. Proteins and peptides with a high aggregation propensity were identified, and selected components were verified biochemically by western blot analysis. Staining by thioflavin T and the Amytracker probe demonstrated the presence of amyloid-like aggregates formed after exposure to LPS in vitro in human wound fluid and in vivo in porcine wound models. Using NF-{kappa}B-reporter mice and IVIS bioimaging, we show that such wound-fluid LPS aggregates induce a significant reduction in local inflammation compared with LPS in plasma. The results show that protein/peptide aggregation is a mechanism for confining LPS and reducing inflammation and further underscore the connection between host defense and amyloidogenesis.